Buyer Beware: THC Breathalyzer Won’t Save Cannabix’s Stock
Cannabix Technologies’ THC breathalyzer could be a huge success if cannabis is legalized in the U.S., but Cannabix’s stock still isn’t a buy.
Read More
Author: Matthew Clark
Fulgent (FLGT): Go Beyond 23andMe With This Surging Genetics Stock
In this episode of The Bull & The Bear podcast, I highlight Fulgent Genetics Inc. (Nasdaq:...
Read More
The $560B EV Boom Is Coming — Profit With 1 Alternative Stock
Magna International Inc.’s (NYSE: MGA) stock is a buy at it supplies key components to some of the largest electric vehicle manufacturers.
Broadcom: This 5G Dividend’s $27B Sales Projection Is Stock Jet Fuel
Broadcom Inc. (Nasdaq: AVGO) is a key player within 5G, and its future sales should send this 5G dividend stock’s price even higher.
Vaccine Boom Over? Watch Pfizer’s Earnings to Find Out
Money & Markets Week Ahead for February 1, 2021: Pfizer’s earnings should tell us how profitable COVID-19 vaccine efforts have been.
Watchlist
